Related Experiment Video
Updated: Aug 2, 2026

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature
Published on: April 1, 2014
Viridans streptococci bacteraemia in children with fever and neutropenia: a case-control study of predisposing
H Paganini1, V Staffolani, P Zubizarreta
1Department of Infectious Diseases, Hospital de Pediatri;a Profesor Dr. Juan P. Garrahan, Buenos Aires, Argentina. hpaganini@intramed.net.ar
Insights
Viridans streptococci (VS) infections are rising in children with cancer and neutropenia. High-dose cytosine-arabinoside chemotherapy and pneumonia independently predict VS bloodstream infections in this vulnerable group.
Area of Science:
- Pediatric Oncology
- Infectious Diseases
- Hematology
Background:
- Viridans streptococci (VS) are an emerging cause of bloodstream infections in neutropenic cancer patients.
- Limited data exists on predisposing factors for VS infections in pediatric oncology patients.
Purpose of the Study:
- To identify risk factors for Viridans streptococci (VS) bloodstream infections in children with cancer and neutropenia.
Main Methods:
- A case-control study analyzed 168 episodes of bloodstream infections in 161 pediatric oncology patients (January 1989-December 1999).
- 15 episodes were caused by VS; each case was matched with six controls (other Gram-positive cocci, Gram-negative bacilli, or no bacteremia).
- Multivariate analysis identified independent predictors for VS bacteremia.
Main Results:
- The median age of patients was 4.1 years; 87% had acute leukemia or lymphomas.
- Pneumonia was the most common clinical focus (70%), and shock occurred in 13% of patients.
- High-dose cytosine-arabinoside (ARA-C) chemotherapy (OR: 9.3) and pneumonia (OR: 1.36) were independent predictors of VS bacteremia.
Conclusions:
- High-dose cytosine-arabinoside (ARA-C) chemotherapy and the presence of pneumonia are significant risk factors for Viridans streptococci bloodstream infections in pediatric cancer patients.
- Further research is warranted to validate these findings and inform preventative strategies.
Abstract:
Viridans streptococci (VS) are an increasing cause of bacteraemia in neutropenic patients with cancer. Case-control studies of predisposing factors for acquisition of this infection in children are not published. Between January 1989 and December 1999, 168 episodes of bacteraemia in 161 children with fever and neutropenia of haemato-oncology origin were analysed. 15 cases (9%) in 15 patients were caused by VS. Each case patient was compared with 6 matched control patients; 2 with other Gram-positive cocci (group 2), 2 with gram-negative bacilli bacteraemia (group 3) and two children with fever and neutropenia without bacteraemia (group 4). The median age of patients was 4.1 years (range: 2-15 years). 87% of children had acute leukaemia or lymphomas. Pneumonia was the predominant clinical focus (70%). Shock was observed in 13% of patients. ARDS was observed in one child who died of this complication. Multivariate analysis of risk factors for the development of VS bacteraemia showed that two factors were independent predictors: high doses of cytosine-arabinoside (ARA-C) as part of the chemotherapy treatment (Odds Ratio (OR): 9.3; Confidence Interval (CI) 1.56-55.5) (P<0.014) and the presence of pneumonia (OR: 1.36: CI 2.27-81.9) (P<0.0043). We propose that further studies are warranted to confirm these results.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Acute Pyelonephritis II: Diagnostic Studies and Management
Bacterial Meningitis
Streptococcal Pharyngitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology

